BTGC becomes an earnings story

Bio-Technology General Corp. said it has turned the corner to profitability. The company reported its first profitable operating period, for the quarter ended March 31, with product sales of $5.2 million and net income of $402,000 ($0.01).

"The critical thing," said William Pursley, newly appointed senior vice president of marketing, sales and commercial development, "is that the company isn't planning any future financings, so there won't be any more dilution in the stock. The company will be earnings-driven from now on."